GHC Highlights Innovation and Global Partnerships at MEDICA 2025

Düsseldorf, Germany – GHC Medical is proud to announce its successful participation in MEDICA 2025, the world’s leading trade fair for the medical sector. Held from November 17–20 in Düsseldorf, the event served as a premier stage for GHC to showcase our latest advancements in Topical Oxygen Therapy (TOT) to an international audience.

 

Building Global Connections
Our team spent four productive days engaging with healthcare providers, distributors, and industry innovators from around the world. The interest in our GHC Topical Oxygen Therapy Chamber System was exceptional, particularly following our recent full MFDS registration in Korea, which has paved the way for expanded clinical applications and international growth.

 

See the Highlights on LinkedIn
We have shared a detailed recap of our experience, including photos from the exhibition floor and key takeaways from our live demonstrations, on our official LinkedIn company page.

​

View our full MEDICA 2025 Recap and Photo Gallery on LinkedIn here: https://www.linkedin.com/feed/update/urn:li:activity:7402419168085790720

​

"Medica 2025 was a landmark event for GHC," said the GHC Leadership Team. "The feedback from the global medical community reinforces the vital role that topical oxygen plays in modern wound care. We want to thank everyone who visited our booth and look forward to the partnerships that began this week."

GHC Attendance Showing at AWCA 7th Global Conference 2025 in Kuala Lumpur, Malaysia

​

GHC Medical is thrilled to announce its highly successful participation in the 7th Global Conference of the Asian Wound Care Association (AWCA), held from October 10th to 12th, 2025, at the prestigious Kuala Lumpur Convention Centre in Malaysia.

As a proud innovator in advanced wound care, GHC showcased its groundbreaking Topical Oxygen Therapy (TOT) Chamber System to a distinguished audience of wound care specialists, researchers, clinicians, and industry leaders from across the globe. Our presence at AWCA 2025 underscored our commitment to advancing wound healing solutions and fostering collaborations within the international medical community.

​

Throughout the conference, the GHC team engaged in vibrant discussions, shared crucial insights, and conducted live demonstrations of our TOT system. Attendees had the opportunity to experience firsthand how our non-invasive, high-concentration oxygen delivery can revolutionize the treatment of chronic and non-healing wounds, including diabetic foot ulcers, venous leg ulcers, and pressure injuries.

​

"Our experience at the AWCA 7th Global Conference was incredibly rewarding. The enthusiasm and interest shown in our Topical Oxygen Therapy system were truly inspiring. It reinforced our belief that GHC is at the forefront of providing effective, patient-centric solutions for complex wound management. We are particularly excited about the new partnerships forged and the potential to bring our technology to even more patients in Asia and beyond."

​

GHC extends its sincere gratitude to the AWCA for organizing such an impactful event and to all the delegates who visited our booth. We look forward to continuing these valuable conversations and contributing to a future where advanced wound care is accessible to all who need it.

GHC Topical Oxygen Therapy Chamber System Receives Full MFDS Registration in South Korea

GHC Medical  is proud to announce that its innovative Topical Oxygen Therapy (TOT) Chamber System has officially received full regulatory registration from the South Korean Ministry of Food and Drug Safety (MFDS).

​

This certification marks a significant milestone in GHC’s mission to expand access to advanced wound care technology globally. The MFDS registration confirms that the GHC TOT system meets the highest standards of safety, quality, and clinical efficacy required by the South Korean medical device market.

​

By delivering oxygen topically, the system stimulates cellular repair and accelerates the healing process, offering a non-invasive and effective solution for patients who have not responded to traditional treatments.

​

 "We are excited to partner with healthcare providers across South Korea to improve patient outcomes and provide a new standard of care for wound management."

​

With this approval, GHC will immediately begin the rollout of the TOT Chamber System to hospitals and specialized wound clinics throughout the country.